Background Bortezomib, thalidomide, and dexamethasone (VTd) plus autologous stem-cell
transplantation is standard treatment in Europe for transplant-eligible patients with newly …

This paper describes the institutions and social norms that have accommodated corruption
in the Russian Federation in the post-transition years. We show how corruption is sustained …

Background The emergence of highly active novel agents has led some to question the role
of autologous haematopoietic stem-cell transplantation (HSCT) and subsequent …

Chronic lymphocytic leukemia (CLL) is a disease of the elderly, characterized by
immunodeficiency. Hence, patients with CLL might be considered more susceptible to severe …

A self-assembled supramolecular complex is reported to catalyze alkyl-alkyl reductive
elimination from high-valent transition metal complexes [such as gold(III) and platinum(IV)], the …

Synthetic chemistry aims to build up molecular complexity from simple feedstocks 1 .
However, the ability to exert precise changes that manipulate the connectivity of the molecular …

Background Randomized trials of venetoclax plus anti-CD20 antibodies as first-line treatment
in fit patients (ie, those with a low burden of coexisting conditions) with advanced chronic …

Daratumumab, a CD38 human monoclonal antibody, demonstrated significant clinical
activity in combination with bortezomib and dexamethasone versus bortezomib and …

Background GLOW is a phase 3 trial evaluating the efficacy and safety of ibrutinib-venetoclax
in older patients and/or those with comorbidities with previously untreated chronic …

Discovery chemists routinely identify purpose-tailored molecules through an iterative structural
optimization approach, but the preparation of each successive candidate in a compound …